129 related articles for article (PubMed ID: 28810293)
1. [Comparative study of three different decalcifying solutions in bone metastasis specimens with breast cancer].
Wu HY; Wang T; Chen KL; Fan ZW; Pu XH; Zhang B; Fan XS; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):536-541. PubMed ID: 28810293
[No Abstract] [Full Text] [Related]
2. Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results.
van Es SC; van der Vegt B; Bensch F; Gerritse S; van Helden EJ; Boon E; Angus L; Overbosch J; Menke-van der Houven van Oordt CW; Verheul HM; van Herpen CML; Jager A; Oosting SF; de Vries EGE; Schröder CP
Am J Surg Pathol; 2019 Oct; 43(10):1355-1360. PubMed ID: 31283631
[TBL] [Abstract][Full Text] [Related]
3. Effect of EDTA decalcification on estrogen receptor and progesterone receptor immunohistochemistry and HER2/neu fluorescence in situ hybridization in breast carcinoma.
Washburn E; Tang X; Caruso C; Walls M; Han B
Hum Pathol; 2021 Nov; 117():108-114. PubMed ID: 34461131
[TBL] [Abstract][Full Text] [Related]
4. Effects of Decalcifying Agents of Variable Duration on PD-L1 Immunohistochemistry.
Strickland AL; Blacketer S; Molberg K; Markantonis J; Lucas E
Am J Clin Pathol; 2020 Jan; 153(2):258-265. PubMed ID: 31603186
[TBL] [Abstract][Full Text] [Related]
5. Effect of Hydrochloric Acid Decalcification on Expression Pattern of Prognostic Markers in Invasive Breast Carcinomas.
Maclary SC; Mohanty SK; Bose S; Chung F; Balzer BL
Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):144-149. PubMed ID: 27028239
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Decalcification Techniques for Rat Femurs Using HE and Immunohistochemical Staining.
Liu H; Zhu R; Liu C; Ma R; Wang L; Chen B; Li L; Niu J; Zhao D; Mo F; Fu M; Brömme D; Zhang D; Gao S
Biomed Res Int; 2017; 2017():9050754. PubMed ID: 28246608
[No Abstract] [Full Text] [Related]
7. [Comparison of two different tissue decalcification methods for immunohistochemistry].
Du J; Liu JY; Su J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):290-4. PubMed ID: 21503129
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu analysis in breast cancer bone metastases.
Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
11. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
[TBL] [Abstract][Full Text] [Related]
12. Advantages of a combined method of decalcification compared to EDTA.
Castania VA; Silveira JW; Issy AC; Pitol DL; Castania ML; Neto AD; Bel EA; Defino HL
Microsc Res Tech; 2015 Feb; 78(2):111-8. PubMed ID: 25452153
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
Sheng L; Wu CY; Chen XF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):684-9. PubMed ID: 21812275
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunohistochemistry with fluorescence in situ hybridization in determining the human epidermal growth factor receptor 2 status of breast cancer specimens: a multicenter study of 3,149 Chinese patients.
Han X; Shi Y; Ma L; Lyu Z; Yang H; Yao J; Li J; Li B; Qin Y
Chin Med J (Engl); 2014; 127(2):246-53. PubMed ID: 24438611
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and comparison of decalcification agents on the human teeth.
Sanjai K; Kumarswamy J; Patil A; Papaiah L; Jayaram S; Krishnan L
J Oral Maxillofac Pathol; 2012 May; 16(2):222-7. PubMed ID: 22923894
[TBL] [Abstract][Full Text] [Related]
16. Tooth decalcification using different decalcifying agents - A comparative study.
Khangura AK; Gupta S; Gulati A; Singh S
J Oral Maxillofac Pathol; 2021; 25(3):463-469. PubMed ID: 35281150
[TBL] [Abstract][Full Text] [Related]
17. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
Yang Y; Lu S; Zeng W; Xie S; Xiao S
Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
[TBL] [Abstract][Full Text] [Related]
18. Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.
Schrijver WA; van der Groep P; Hoefnagel LD; Ter Hoeve ND; Peeters T; Moelans CB; van Diest PJ
Mod Pathol; 2016 Dec; 29(12):1460-1470. PubMed ID: 27562496
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of various decalcification techniques.
Prasad P; Donoghue M
Indian J Dent Res; 2013; 24(3):302-8. PubMed ID: 24025875
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.
Pérez-Fidalgo JA; Eroles P; Ferrer J; Bosch A; Burgués O; Martínez F; Bermejo B; Lluch A; González-Angulo AM
Breast; 2013 Oct; 22(5):974-9. PubMed ID: 23809906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
